Enoxaparin (Lovenox)

ATI-format individual drug card with NCLEX-focused assessment, safety, teaching, and source attribution.

Back to meds
CardiacHematologic / ImmuneRenal / Urinary / Electrolytesneeds review

Enoxaparin (Lovenox)

ATI class: Anticoagulant / Low molecular weight heparin

Action

  • ATI/source-folder candidate for Enoxaparin (Lovenox); verify mechanism against the source table before validation.

Therapeutic use

  • Review under Coagulation Disorders medication safety.

Nursing assessment

  • Assess bleeding, bruising, platelet count, renal function, weight, and injection sites.
  • Review timing around surgery, neuraxial anesthesia, or procedures.
  • Monitor anti-Xa only when ordered for high-risk clients.

Administration

  • Verify route against the order and source table.

Side effects

  • Verify common side effects against the source table.

Adverse effects

  • Bleeding
  • Spinal or epidural hematoma risk with neuraxial procedures
  • Thrombocytopenia
  • Injection-site hematoma

Interactions

  • Antiplatelets
  • NSAIDs
  • Warfarin
  • Thrombolytics
  • Other anticoagulants

Contraindications

  • See source-specific contraindications and precautions before administration.

Precautions

  • Active major bleeding or history of HIT with heparin products.
  • Use caution with renal impairment, low body weight, older adults, pregnancy protocols, and neuraxial procedures.

Client teaching

  • Inject subcutaneously as taught and do not rub the site.
  • Report bleeding, black stools, severe headache, weakness, back pain after neuraxial procedures, or blood in urine.
  • Avoid unapproved NSAIDs and high-risk activities.

Medication outcomes

  • Therapeutic response with no priority adverse effects.

Antidote / rescue

  • No specific antidote is seeded; hold/question unsafe doses and manage toxicity per provider, facility, or poison-control guidance.

NCLEX priority cues

  • Renal impairment increases accumulation and bleeding risk.
  • New neurologic symptoms after spinal/epidural context are urgent.
  • Do not massage injection sites.

Medication classes

Anticoagulants

Source attribution

Google Drive source topic: Coagulation Disorders
google-drive
Sentinel pharmacology API reference
sentinel-api
Manual ATI-format NCLEX candidate normalization
manual-seed

Related study cards

Shows the medication class, ATI cues, source references, and connected study cards for this drug.

12 study links
Med classmedication class
Anticoagulants

Reduces clot formation by interfering with the coagulation cascade.

ATI cuePrecaution
Active major bleeding or history of HIT with heparin products.

ATI medication precaution concept.

ATI cueClass
Anticoagulant

ATI medication class concept.

ATI cueInteraction
Antiplatelets

ATI medication interaction concept.

ATI cueNursing Assessment
Assess bleeding, bruising, platelet count, renal function, weight, and injection sites.

ATI medication nursing assessment concept.

ATI cueMechanism of Action
ATI/source-folder candidate for Enoxaparin (Lovenox); verify mechanism against the source table before validation.

ATI medication mechanism of action concept.

ATI cueClient Teaching
Avoid unapproved NSAIDs and high-risk activities.

ATI medication client teaching concept.

ATI cueAdverse Effect
Bleeding

ATI medication adverse effect concept.

ATI cueNCLEX Priority Cue
Do not massage injection sites.

ATI medication nclex priority cue concept.

ATI cueClient Teaching
Inject subcutaneously as taught and do not rub the site.

ATI medication client teaching concept.

ATI cueAdverse Effect
Injection-site hematoma

ATI medication adverse effect concept.

ATI cueClass
Low molecular weight heparin

ATI medication class concept.